Related Experiment Videos

Wilms tumor in a patient with Prader-Willi syndrome

M J Coppes1, H Sohl, I E Teshima

  • 1Department of Cancer Biology, Cleveland Clinic Foundation, Ohio.

Insights

Prader-Willi syndrome, a genetic disorder, was linked to Wilms tumor in a patient. Genetic analysis revealed a paternal deletion on chromosome 15q11-q13, implicating parent-of-origin effects in both conditions.

Area of Science:

  • Genetics
  • Pediatric Oncology
  • Developmental Biology

Background:

  • Prader-Willi syndrome is a complex genetic disorder associated with specific imprinting patterns on chromosome 15.
  • Wilms tumor is a pediatric kidney cancer with known tumor suppressor genes on chromosome 11p.
  • Parent-of-origin effects, where gene expression differs based on parental inheritance, are documented for both conditions.

Observation:

  • A patient with Prader-Willi syndrome developed Wilms tumor.
  • Genetic investigation focused on the parental origin of implicated genes due to known parent-of-origin effects.
  • Analysis aimed to identify deletions or alterations in critical chromosomal regions.

Findings:

  • A deletion was identified in the paternal chromosome 15q11-q13 region, consistent with Prader-Willi syndrome.
  • A limited analysis of chromosome 11p, which contains Wilms tumor suppressor genes WT1 and WT2, showed no detectable changes.
  • This suggests the observed Wilms tumor development may not be directly linked to alterations in WT1 or WT2 in this case.

Implications:

  • The findings highlight the complex interplay between genetic syndromes and cancer development.
  • Understanding parent-of-origin effects is crucial for diagnosing and managing associated conditions.
  • Further research is needed to elucidate the mechanisms linking Prader-Willi syndrome and Wilms tumor, potentially involving novel genetic or epigenetic factors.

Related Concept Videos